Cargando…
Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
PURPOSE: Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in phase 3 clinical development for glaucoma treatment. We investigated the effects of its active metabolite, netarsudil-M1, on outflow facility (C), outflow hydrodynamics, and morphology of the conventional outflow p...
Autores principales: | Ren, Ruiyi, Li, Guorong, Le, Thuy Duong, Kopczynski, Casey, Stamer, W. Daniel, Gong, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114035/ https://www.ncbi.nlm.nih.gov/pubmed/27842161 http://dx.doi.org/10.1167/iovs.16-20189 |
Ejemplares similares
-
The β(4)-Subunit of the Large-Conductance Potassium Ion Channel K(Ca)1.1 Regulates Outflow Facility in Mice
por: Bertrand, Jacques A., et al.
Publicado: (2020) -
Acute Effects of Intraocular Pressure-Induced Changes in Schlemm's Canal Morphology on Outflow Facility in Healthy Human Eyes
por: Chen, Wei, et al.
Publicado: (2020) -
Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation
por: Hu, Yan, et al.
Publicado: (2019) -
An In Vitro Perfusion System to Enhance Outflow Studies in Mouse Eyes
por: Kizhatil, Krishnakumar, et al.
Publicado: (2016) -
Comparison of Aqueous Outflow Facility Measurement by Pneumatonography and Digital Schiøtz Tonography
por: Kazemi, Arash, et al.
Publicado: (2017)